Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study
Tim Spelman, Murat Terzi, José Luis Sánchez-Menoyo, Jeannette Lechner‐Scott et al.
Citations
1 citations
Journal
Multiple Sclerosis and Related Disorders
Topics
Multiple Sclerosis Research Studies
Field-Weighted Citation Impact (FWCI)
1.47
article
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study
Tim Spelman, Murat Terzi, José Luis Sánchez-Menoyo, Jeannette Lechner‐Scott, Guy Laureys, Allan G. Kermode, Tomáš Kalinčík, Helmut Butzkueven, Erwan Muros‐Le Rouzic, Anneke van der Walt, Juan Ignacio Rojas, Raed Alroughani, Cavit Boz, François Grand’Maison, Petra Dirks, Matteo Foschi, Barbara Willekens, Cristina Ramo‐Tello, Eli Skromne, Michael Harry Barnett, Vincent Van Pesch, Serkan Özakbaş, Olga Skibina, Lisa Taylor, Pamela Farr, Katherine Buzzard
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Multiple Sclerosis and Related DisordersVol. 106
Institutions
Roche (Switzerland) (CH), The University of Sydney (AU), Cliniques Universitaires Saint-Luc (BE), The Royal Melbourne Hospital (AU), Box Hill Hospital (AU), İzmir University of Economics (TR), Karadeniz Technical University (TR), Mexican Social Security Institute (MX), The University of Melbourne (AU), The University of Western Australia (AU), Ondokuz Mayıs University (TR), Ghent University Hospital (BE), The Alfred Hospital (AU), Amiri Hospital (KW), Karolinska Institutet (SE), Ospedale "Santa Maria delle Croci" di Ravenna (IT), Eastern Health (AU), Hospital Universitario Austral (AR), Antwerp University Hospital (BE), Hospital de Galdakao (ES), Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR), Hospital Universitari Germans Trias i Pujol (ES), Alfred Health (AU), Monash University (AU), University of Newcastle Australia (AU), UCLouvain (BE)